Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'.

Martora, Fabrizio; Marasca, Claudio; Battista, Teresa; Fabbrocini, Gabriella; Ruggiero, Angelo

Martora, Fabrizio; Marasca, Claudio; Battista, Teresa; Fabbrocini, Gabriella; Ruggiero, Angelo.

Martora F; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Marasca C; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Battista T; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Ruggiero A; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Clin Exp Dermatol ; 47(11): 2026-2028, 2022 11.

Article in English | MEDLINE | ID: covidwho-1973584

Subject(s)

COVID-19; Hidradenitis Suppurativa; Humans; Hidradenitis Suppurativa/complications; Hidradenitis Suppurativa/drug therapy; COVID-19 Vaccines/adverse effects; COVID-19/prevention & control; Vaccination/adverse effects; Italy/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hidradenitis Suppurativa / COVID-19 Type of study: Experimental Studies / Observational study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Clin Exp Dermatol Year: 2022 Document Type: Article Affiliation country: Ced.15306

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google